Katalyze AI lands $10.5M seed to automate pharma workflows

What's the deal? Katalyze AIDealroom has a profile for this one. Try Dealroom →, an agentic operating system for pharmaceutical companies, has raised a $10.5 million seed round, chief executive officer Reza Farahani told Axios in an exclusive.

What's the endgame? The startup is building software to automate the management of workflow bottlenecks across pharma development and manufacturing.

The signal: Investors are increasingly backing companies that automate pharma bottlenecks, as patent cliffs push the industry toward faster development and manufacturing.

Read more: Axios

Image credit: USDAgov